Cizzle Brands Corporation (N: CZZL) is an emerging leader in the health & wellness industry. Their mission is to replace all of the unhealthy, sugary and fattening foods and fill our cupboards with healthy, nutritious alternatives. Here to dive into the world of hea...
Lyndsay Malchuk
|
20 hours ago
|
Futures Fall Amid Rate Cut Uncertainty Futures tied to Canada’s main stock index slid on Monday, tracking declines in U.S. markets, as a strong U.S. jobs report erased expectations of interest rate cuts in 2025. It’s a tough morn...
Lyndsay Malchuk
|
22 hours ago
|
Futures tracking Canada’s main stock index ticked up on Friday as investors await pivotal U.S. payroll and domestic employment data, which could shape the interest rate trajectory in both economies. The TSX maintained gains, while the Venture Index edg...
Lyndsay Malchuk
|
3 days ago
|
Richard De Sousa of the Rich TV Live podcast serves up his latest Stocks to Watch, exclusively for Stockhouse . De Sousa touches on buying opportunities in Bitcoin, Ethereum, The Magnificent Seven Stocks, FuboTV, Roku and more in this week’s Rich TV...
Rich TV Live
|
4 days ago
|
An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...
The past week has been eventful for the TSX , reflecting the broader economic and political landscape. Monday: Canada’s main stock index managed to maintain composure, registering a controlled loss following the unexpected resignation of Prime Minis...
Jonathon Brown
|
4 days ago
|
Almonty Industries Inc.(TSX:AII) , a company who specializes in acquiring and optimizing distressed and underperforming tungsten operations and assets. Lyndsay Malchuk, with the Market Online, recently had the pleasure to sit down with President and CEO Lewis Black. ...
Lyndsay Malchuk
|
December 27, 2024
|
It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...
Knox Henderson
|
December 23, 2024
|
As the festive season approaches, mid-cap stocks often present overlooked opportunities for investors seeking growth and stability in their portfolios. This asset class combines the agility of smaller firms with the reliability of established players, making them an ...
Lyndsay Malchuk
|
December 21, 2024
|
As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...
Coreena Robertson
|
December 19, 2024
|